Nature Reviews Cancer 17, 254–268 (2017)
In the online html version of this article, Joan Seoane's affiliations were not correct. He is also a member of the EurOPDX Consortium and is at the Vall d'Hebron Institute of Oncology, 08035 Barcelona, the Universitat Autònoma de Barcelona, 08193 Bellaterra, and the Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. This is correct in the print and PDF versions of the article.
Change history
31 October 2017
When the October issue was published online, this article was initially missed out. It has now been moved into the issue. The article was correctly included in the print edition.
Additional information
The online version of the original article can be found at 10.1038/nrc.2016.140
Rights and permissions
About this article
Cite this article
Byrne, A., Alférez, D., Amant, F. et al. Erratum: Interrogating open issues in cancer medicine with patient-derived xenografts. Nat Rev Cancer 17, 632 (2017). https://doi.org/10.1038/nrc.2017.85
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrc.2017.85
This article is cited by
-
Zebrafish patient-derived xenograft models predict lymph node involvement and treatment outcome in non-small cell lung cancer
Journal of Experimental & Clinical Cancer Research (2022)
-
Organoid technology and applications in cancer research
Journal of Hematology & Oncology (2018)
-
Anti-angiogenic drug scheduling optimisation with application to colorectal cancer
Scientific Reports (2018)
